Christopher R. Friese, PhD, RN, AOCN®, FAAN, is the 2015 recipient of the Rose Mary Carroll-Johnson Distinguished Award for Consistent Contribution to the Nursing Literature. Friese's work has been praised for its interdisciplinary nature and appears across diverse scientific journals., He is an assistant professor at the University of Michigan School of Nursing in Ann Arbor.
Search Results for "publications ONF"
ONS Announces Winner of Distinguished Award for Contribution to Nursing Literature
Thursday, March 26, 2015
Christopher R. Friese, PhD, RN, AOCN®, FAAN, of Ann Arbor, MI, is the recipient of the Oncology Nursing Society (ONS) 2015 Rose Mary Carroll-Johnson Distinguished Award for Consistent Contribution to the Nursing Literature. This award recognizes the impact that he has made on the oncology nursing profession through his high-quality research publications, his dissemination of findings for policymakers and practitioners, and his efforts to support the professional development of colleagues. He will be honored for the award at the opening ceremony of the ONS 40th Annual Congress in Orlando, FL, on April 23, 2015.
Friese is an assistant professor at the University of Michigan School of Nursing in Ann Arbor. Since he began his career in 1997, he has conducted research to measure and improve the quality and safety of cancer care delivery. His 51 peer-reviewed manuscripts have been published in the Oncology Nursing Forum, Clinical Journal of Oncology Nursing, BMJ Quality and Safety, Cancer, Cancer Nursing, Health Services Research, and Medical Care. A hallmark of his publications is their interdisciplinary nature, from his co-authors and collaborators to the diverse scientific journals in which he has been published.
“Receiving this award from ONS means a great deal to me and my research collaborators,” said Friese. “I am glad that my publications that examine quality of cancer nursing care are valued by my fellow oncology nurses. I am especially grateful to participants in our research studies, who make our publications possible.”
Friese received his bachelor of science in nursing degree and PhD from the University of Pennsylvania School of Nursing in Philadelphia. He completed a post-doctoral fellowship at the Dana-Farber Cancer Center and Harvard School of Public Health in Boston, MA. He is an active member of the Ann Arbor and Metro Detroit Chapters of ONS, the ONS Research Special Interest Group, and the American Society of Clinical Oncology, and he is also a fellow in the American Academy of Nursing. He currently directs the DEFENS Study, a four-year, $2.3-million study to understand and improve the safety of chemotherapy administration. In addition to his appointment in the School of Nursing, Friese is a core member of both the Comprehensive Cancer Center and the Institute for Healthcare Policy and Innovation at the University of Michigan.
ONS is a professional association of more than 35,000 members committed to promoting excellence in oncology nursing and the transformation of cancer care. Since 1975, ONS has provided a professional community for oncology nurses, developed evidence-based education programs and treatment information, and advocated for patient care, all in an effort to improve quality of life and outcomes for patients with cancer and their families.